09-12, 14:00–14:30 (Europe/Istanbul), Head & Neck Surgery 3
Transoral Robotic Surgery rapresents a defined and well standarzided surgical therapy for oropharyngeal cancer, despite many open questions remain, particularly regarding the role of first-line treatment in comparison with radiotherapy and chemiotherapy.
Based on personal experience we will try to compare our surgical outcomes, in comparison with radiotherapy and chemiotherapy protocols applied in our institution and reported in the specific literature.
Andrea De Vito is currently ENT Unit Director at Morgagni-Pierantoni Hospital. His is an experienced surgeon in head and neck oncologic surgery, middle ear surgery, with special experience in Laser CO2 laryngeal surgery, and Trans Oral Robotic surgery for oncologic and patients affected by Sleep-Disordered Breathing (SDB), collecting more than 9.000 surgical procedures, certified by Logo 80 digital system, HLA of Romagna. His special interest on SDB diagnosis and treatment option, and head and neck oncology are confirmed by more than 90 publications on IF journals. He is currently Chair for the scientific national commission on SDB for Italian Association of OtoRhinoLaryngology & Head and Neck Surgery, EOS.DRS master course teacher and tutor (2010-2023) and EOS.DRS master course co-director 2023-2024. He is an active member of Italian Society of Otorhinolaryngology, Head & Neck Surgery and World Sleep Association.
Dr. David Virós Porcuna is Chief of the Department of Otolaryngology – Head and Neck Surgery at Vall d’Hebron University Hospital in Barcelona (Spain). His clinical work focuses on oncologic head and neck surgery, with particular dedication to minimally invasive approaches such as transoral robotic surgery (TORS). He has developed solid experience applying robotic techniques in complex scenarios including oropharyngeal tumors, parapharyngeal space lesions, salvage surgery after chemoradiotherapy, and neck surgery. He has contributed to the structured implementation and consolidation of robotic surgery programs within his institution, participating in the development of protocols for challenging anatomical areas and optimizing surgical outcomes through multidisciplinary collaboration. His group works closely with radiology, oncology, anesthesiology, and 3D planning teams to advance personalized surgical strategies. In parallel to his clinical work, Dr. Virós is an Associate Professor of Otolaryngology at the Autonomous University of Barcelona (UAB), where he has been involved in undergraduate and postgraduate teaching since 2015. He has supervised doctoral theses and final degree projects, especially in the fields of robotic surgery, oncology, and surgical innovation. Dr. Virós is also co-leader of a translational research group at the Vall d’Hebron Institute of Research (VHIR), focused on tumor stem cells and molecular mechanisms of head and neck cancer. His team explores novel therapeutic targets and predictive biomarkers, and collaborates in clinical trials and translational projects. He has recently joined a European telemedicine initiative aimed at developing home-based audiological monitoring tools for oncology patients undergoing ototoxic treatments, combining AI models and digital health applications. He has authored over 30 peer-reviewed publications and book chapters, and frequently participates in international meetings as a speaker or panelist.
He has organized and directed several hands-on international training courses in transoral anatomy and parapharyngeal space surgery, providing practical education to head and neck surgeons.